July 07, 2020
The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 3 July 2020 it purchased 99,999 ordinary shares of 1p in the capital of the Company ("Ordinary Shares") at a price of 3.90p per Ordinary Share (the “Purchase”). Following the Purchase, Vulpes has a total direct and indirect interest in 65,463,157 Ordinary Shares, equivalent to 22.18% of Proteome Sciences' total issued share capital.